Drug intelligence / Profile preview

H-Al pollens grass mixture I

Development stage
Unknown
Lead developer
Sevapharma
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Oral, Sublingual
01

Overview

H-Al pollens grass mixture I is a standardized allergen extract developed by SEVAPHARMA a.s. for allergen-specific immunotherapy (AIT). It is indicated for the treatment of IgE-mediated type I allergic conditions, specifically allergic rhinitis induced by grass pollen. The product contains a standardized mixture of grass pollen allergens and is administered via oral or sublingual routes. Its mechanism of action involves the modulation of the immune system to induce tolerance to grass pollen antigens, thereby reducing the allergic response mediated by IgE antibodies.

Other names
H-Al pollens Grass mixture I
02

Targets

BCR (Immunoglobulin G B Cell Receptor)TCR (Grass pollen allergen-specific CD4+ T-cell receptor)Phl p (Timothy grass pollen allergen)

Beyond the preview

Go deeper on H-Al pollens grass mixture I.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on H-Al pollens grass mixture I.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call